Sign in
4

Changes in Ownership

Phathom Pharmaceuticals, Inc. Filed Acc 0000950170-25-075870

Options or other derivatives

  • Principal Accounting Officer acquired 33,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Breedlove Robert Charles Principal Accounting Officer 2025-05-19 Grant or award · Stock Option (Right to Buy) +33,000 33,000 D
Loading xslF345X05/ownership.xml…